Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

16.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

6.3K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.3K
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

172
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
172
Local Anesthetics: Common Agents and Their Applications01:23

Local Anesthetics: Common Agents and Their Applications

443
Local anesthetics (LAs) are commonly used for various applications in medical and dental procedures. Some of the common agents used are cocaine, lidocaine, and bupivacaine.
Cocaine is an ester of benzoic acid and methylecgogine. It is used to anesthetize and vasoconstrict locally. Currently, it is used primarily for topical applications. It is beneficial for surgeries on the upper respiratory tract, providing anesthesia and shrinking the mucosa. Cocaine in the form of cocaine hydrochloride is...
443
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

3.8K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
3.8K
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Determination of Self-(In)compatibility and Inter-(In)compatibility Relationships in Citrus Using Manual Pollination, Microscopy, and S-Genotype Analyses.

Journal of visualized experiments : JoVE·2023
Same author

χ<sup>(2)</sup> nonlinear photonics in integrated microresonators.

Frontiers of optoelectronics·2023
Same author

Risk-reducing salpingo-oophorectomy among Chinese women at increased risk of breast and ovarian cancer.

Journal of ovarian research·2023
Same author

The elevated toxicity of the biodegradation product (guanylurea) from metformin and the antagonistic pattern recognition of combined toxicity: Insight from the pharmaceutical risk assessment and the simulated wastewater treatment.

The Science of the total environment·2023
Same author

Portal vein embolization combined with ex vivo liver resection and autotransplantation: A novel treatment strategy for end-stage and metastatic hepatic alveolar echinococcosis.

Hepatobiliary & pancreatic diseases international : HBPD INT·2023
Same author

The prognosis of patients with small cell carcinoma of the cervix: a retrospective study of the SEER database and a Chinese multicentre registry.

The Lancet. Oncology·2023

Related Experiment Video

Updated: Jul 2, 2025

Author Spotlight: Advancing Facial Rejuvenation Therapy with Post-Laser Salicylic Acid Application
03:47

Author Spotlight: Advancing Facial Rejuvenation Therapy with Post-Laser Salicylic Acid Application

Published on: September 27, 2024

879

Small-molecule agents for treating skin diseases.

Hong Cai1, Hao Wen1, Junjie Li1

  • 1School of Pharmacy, Hangzhou Normal University, Hangzhou, 311121, PR China; Key Laboratory of Elemene Class Anti-Cancer Chinese Medicines, Engineering Laboratory of Development and Application of Traditional Chinese Medicines, Collaborative Innovation Center of Traditional Chinese Medicines of Zhejiang Province, Hangzhou Normal University, Hangzhou, 311121, PR China.

European Journal of Medicinal Chemistry
|February 29, 2024
PubMed
Summary
This summary is machine-generated.

Developing new small-molecule drugs is crucial for treating skin diseases, as current treatments offer limited efficacy. This review explores disease mechanisms, existing therapies, and emerging drug candidates to guide future dermatological research.

Keywords:
Drug discoveryMedicinal chemistrySkin diseasesStructural modification

More Related Videos

Author Spotlight: Enhancing Skin Model Diversity with Cost-Effective 3D Cellular Models
08:32

Author Spotlight: Enhancing Skin Model Diversity with Cost-Effective 3D Cellular Models

Published on: October 20, 2023

2.6K
Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications
08:19

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications

Published on: November 17, 2015

17.9K

Related Experiment Videos

Last Updated: Jul 2, 2025

Author Spotlight: Advancing Facial Rejuvenation Therapy with Post-Laser Salicylic Acid Application
03:47

Author Spotlight: Advancing Facial Rejuvenation Therapy with Post-Laser Salicylic Acid Application

Published on: September 27, 2024

879
Author Spotlight: Enhancing Skin Model Diversity with Cost-Effective 3D Cellular Models
08:32

Author Spotlight: Enhancing Skin Model Diversity with Cost-Effective 3D Cellular Models

Published on: October 20, 2023

2.6K
Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications
08:19

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications

Published on: November 17, 2015

17.9K

Area of Science:

  • Dermatology and Drug Discovery
  • Pharmacology and Therapeutics

Background:

  • Skin diseases significantly impact daily life, with current treatments often providing only symptomatic relief.
  • There is a critical need for novel small-molecule drugs offering improved efficacy and potential cures for various skin conditions.
  • Existing therapeutic options are insufficient to meet the clinical demand for effective skin disease management.

Purpose of the Study:

  • To systematically review the pathogenesis of common skin diseases.
  • To compile a list of currently used clinical drugs for skin conditions.
  • To summarize the clinical research status of candidate drugs and recent advancements in drug discovery for skin diseases.

Main Methods:

  • Literature review of pathogenesis and clinical treatments for common skin diseases.
  • Analysis of clinical research status for candidate drugs.
  • Summary of recent progress in small-molecule compound discovery.
  • Statistical analysis of publication trends and global research attention.

Main Results:

  • Identified gaps in current therapeutic strategies for skin diseases.
  • Cataloged existing and investigational drugs for various dermatological conditions.
  • Highlighted the progress in developing novel small-molecule compounds.
  • Provided insights into research trends and global interest in skin disease therapeutics.

Conclusions:

  • The review offers practical information for researchers in dermatological drug development.
  • It underscores the importance of advancing small-molecule drug discovery for more effective skin disease treatments.
  • Increased research focus on skin diseases is encouraged to address unmet clinical needs.